HK Stock Market Move | REMEGEN (09995) rises over 4%, plans to repurchase company A-shares for RMB30 million to RMB60 million

REMEGEN (09995) rose over 4%, up 4.64% as of press time at HK$65.45, with a turnover of HK$30.6455 million. On the news front, on November 2, REMEGEN announced that the company's board of directors approved the "Proposal on the Second Share Repurchase Plan of 2026 by Way of Centralized Bidding," intending to use the company's own funds and/or self-raised funds to repurchase the company's A-shares through centralized bidding. The repurchased shares will be used to safeguard the company's value and shareholders' rights and interests. The repurchase amount shall be no less than RMB30 million (inclusive) and no more than RMB60 million (inclusive), and the repurchase price shall not exceed RMB131 per share (inclusive). In addition, REMEGEN announced that as of October 31, 2026, the company had cumulatively repurchased 60,000 shares through the Shanghai Stock Exchange trading system by way of centralized bidding, accounting for 0.0106% of the company's total share capital. The highest repurchase price was RMB113.7 per share and the lowest was RMB108.30 per share, with a total amount paid of RMB6.632 million (excluding transaction commissions and other transaction fees).